Walleye Capital’s Akcea Therapeutics Inc AKCA Stock Holding History

Walleye Capital’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-49,226	Closed	-$893K	–	1296
2020 Q3	$893K	Buy	+49,226	New	+$698K	0.1%	266

Walleye Capital's AKCA Position: Q4 2020 in Review

Walleye Capital sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 49,226 shares — an estimated $893K sold.

Walleye Capital first reported a position in AKCA in Q3 2020 and held it in 1 quarter. The position peaked at $893K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Walleye Capital reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Walleye Capital sold 49,226 Akcea Therapeutics Inc shares in Q4 2020, an estimated $893K.
Walleye Capital first reported a position in Akcea Therapeutics Inc in Q3 2020 and held it in 1 quarter.
Walleye Capital's Akcea Therapeutics Inc position peaked at $893K in Q3 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Walleye Capital's 13F filing for Q4 2020, filed 16 Feb 2021.